Belluscura is a medical device company that focused on novel oxygen-based treatment platforms. They are a license and develop proprietary technologies that can be applied across a range of treatment possibilities. Belluscura is focused on disruptive treatment platforms so that their technology can be adapted and applied in a wide range of markets beyond those traditionally applied to a single product or product line. Belluscura was founded in 2015 and is based in London, Farringdon.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.